Internal Medicine, Hematology & Oncology · Orange, CA
NPI
1639259872
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
Uci Medical Center, 101 the City Drive South
Orange, CA, 92868
Phone (714) 456-8978
Groups this clinician bills Medicare through
Medicare paid, 2024
$69K
953 services
Medicare patients, 2024
137
Average age 73
Drug cost, 2024
$4.9M
711 prescriptions
Company payments, 2025
$1,170
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sai-Hong I Ou was code 99214 (office e&m - established), 367 times for 96 patients. In total Sai-Hong I Ou billed 953 services in 11 codes, and Medicare paid $69K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-01-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 367 | 96 | $79.83 | $29K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 273 | 96 | $14.68 | $4,007 |
| 99215 Office E&M - Established | Facility | 203 | 69 | $119.79 | $24K |
| 99205 Office E&M - New | Facility | 27 | 27 | $145.24 | $3,921 |
| 99214 Office E&M - Established | Office | 18 | 16 | $87.25 | $1,571 |
By year: 2022 $65K for 778 services; 2023 $60K for 625 services; 2024 $69K for 953 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sai-Hong I Ou prescribed most often to Medicare patients was Tagrisso (Osimertinib Mesylate), with 124 prescriptions and refills. In total Sai-Hong I Ou wrote 711 Medicare prescriptions that cost $4.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tagrisso Osimertinib Mesylate | 124 | 127 | 17 | $2.1M |
| Dexamethasone Generic | 46 | 46 | 17 | $364 |
| Ondansetron Hcl Generic | 29 | 29 | 15 | $246 |
| Retevmo Selpercatinib | 27 | 27 | Under 11 | $620K |
| Gilotrif Afatinib Dimaleate | 26 | 26 | Under 11 | $267K |
| Sodium Chloride 0.9 % Sodium Chloride | 25 | 25 | Under 11 | $866 |
| Iressa Gefitinib | 24 | 24 | Under 11 | $175K |
| Eliquis Apixaban | 24 | 33 | Under 11 | $20K |
| Alecensa Alectinib Hcl | 21 | 21 | Under 11 | $387K |
| Olanzapine Generic | 21 | 21 | Under 11 | $21.87 |
| Megestrol Acetate Generic | 20 | 32 | Under 11 | $1,148 |
| Furosemide Generic | 15 | 17 | Under 11 | $40.06 |
| Prochlorperazine Maleate Generic | 15 | 15 | Under 11 | $173 |
| Atorvastatin Calcium Generic | 15 | 23 | Under 11 | $37.77 |
| Potassium Chloride Generic | 14 | 28 | Under 11 | $323 |
Brand drugs: 358 claims; generic drugs: 353 claims; opioid claims: 21.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sai-Hong I Ou $1,170 ($1,170 in general payments such as food, travel and fees) from 16 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $700.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.